Epidemiology, biology and pathology: Molecular and cell biology. Useful biomarkers. Pathology. Incidence and epidemiological data. Smoking and tobacco control. Professional risks and environment factors.- Early detection, diagnosis and staging: Radiological screening. Endoscopy detection. Clinical presentation and paraneoplastic syndromes. Differential diagnosis. Imaging (RX, CT, MRI, US). PET scan. Pathological diagnosis obtention. Mediastinal staging. Operability assessment. TNM staging.- Treatment: Non small cell lung cancer. Surgery. Neoadjuvant treatments. Adjuvant treatments. Elective radiotherapy. Chemotherapy. Salvage therapy. Small cell lung carcinoma. Limited disease. Extensive disease. Preventive cranial irradiation. Salvage therapy. Chemoprevention. Endoscopic treatments. Biological treatments.- Complications and supportive care: BM aplasia. SVCS. Airway obstruction. Malignant pleural effusion. Symptomatic treatment. Palliative care.- Prognosis: NSCLC prognosis. SCLC prognosis.
From the reviews: "Lung cancer is a global epidemic a ] . Malignant Tumors of the Lung comes at a time when there are more options and perhaps less nihilism in the treatment of this disease. a ] The high points of the book are the illustrations, tables and charts. This is essential reading for medical professionals involved in the care of patients with lung cancer." (Nithya Ramnath, Oncology, Vol. 67 (56), 2004)
![]() |
Ask a Question About this Product More... |
![]() |